Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
NDRA ENDRA Life Sciences Inc
- Stocks
- Healthcare
- NASDAQ: NDRA
Price (delayed)
$3.56
Market cap
$2.63M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$126.2
Enterprise value
$1.54M
ENDRA Life Sciences is the pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), a ground-breaking technology being developed to visualize tissue like MRI, but at 1/50th the cost and at the
Highlights
The debt has decreased by 29% from the previous quarter
ENDRA Life Sciences's net income has increased by 15% from the previous quarter
The company's EPS has shrunk by 122% QoQ but it has surged by 94% YoY
NDRA's equity has dropped by 53% year-on-year and by 32% since the previous quarter
The company's quick ratio fell by 32% QoQ
Key stats
What are the main financial stats of NDRA
Market
Valuations
Earnings
Shares outstanding
738,370
Market cap
$2.63M
Enterprise value
$1.54M
Price to earnings (P/E)
N/A
Price to book (P/B)
1.14
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Operating income
-$9.52M
Net income
-$9.77M
EBIT
-$9.77M
EBITDA
-$9.57M
Free cash flow
-$6.56M
Per share
Balance sheet
Liquidity
EPS
-$126.2
EPS diluted
-$126.2
Free cash flow per share
-$11.76
Book value per share
$3.12
Revenue per share
$0
TBVPS
$5.69
Total assets
$3.17M
Total liabilities
$1.42M
Debt
$978,025
Equity
$1.75M
Working capital
$1.61M
Debt to equity
0.56
Current ratio
3.85
Quick ratio
3.65
Net debt/EBITDA
0.11
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-147.8%
Return on equity
-196.2%
Return on invested capital
-373.6%
Return on capital employed
-375%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
NDRA stock price
How has the ENDRA Life Sciences stock price performed over time
Intraday
2.3%
1 week
10.39%
1 month
-42.07%
1 year
-97.61%
YTD
-43.13%
QTD
-13.17%
Financial performance
How have ENDRA Life Sciences's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$9.52M
Net income
-$9.77M
Gross margin
N/A
Net margin
N/A
ENDRA Life Sciences's net income has increased by 15% from the previous quarter
The operating income rose by 12% since the previous quarter and by 4.1% year-on-year
Price vs fundamentals
How does NDRA's price correlate with its fundamentals
Growth
What is ENDRA Life Sciences's growth rate over time
Valuation
What is ENDRA Life Sciences stock price valuation
P/E
N/A
P/B
1.14
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The company's EPS has shrunk by 122% QoQ but it has surged by 94% YoY
NDRA's P/B is 63% more than its last 4 quarters average of 0.7 but 62% less than its 5-year quarterly average of 3.0
NDRA's equity has dropped by 53% year-on-year and by 32% since the previous quarter
Efficiency
How efficient is ENDRA Life Sciences business performance
The company's return on invested capital fell by 12% YoY but it rose by 2.8% QoQ
The ROA has increased by 9% since the previous quarter but it has declined by 7% year-on-year
The return on equity has grown by 7% since the previous quarter but it has declined by 7% year-on-year
Dividends
What is NDRA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for NDRA.
Financial health
How did ENDRA Life Sciences financials performed over time
NDRA's total assets is 124% greater than its total liabilities
NDRA's total assets is down by 37% year-on-year and by 29% since the previous quarter
ENDRA Life Sciences's current ratio has decreased by 32% QoQ
The debt is 44% less than the equity
NDRA's equity has dropped by 53% year-on-year and by 32% since the previous quarter
The debt has decreased by 29% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.